Neogen Chemicals Ltd received a disclosure under SEBI regulations stating that Dr. Harin Haridas Kanani acquired 1,338,250 equity shares (5.07% of equity) via an off-market transfer from another promoter; the aggregate promoter holding remains unchanged. This transaction was exempt under regulation 10(1)(a)(ii) of SEBI (SAST) Regulations.